GlassScriptPhysician profile
P Truett Ray
NPI 1669411773
$403.50
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $81.71 · 2022: $14.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $131.34 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $69.64 | 2019-2020 | |
| Antares Pharma, INC. | $43.85 | 2019-2020 | |
| Abbvie INC. | $43.71 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.54 | 2019-2020 | |
| Allergan, INC. | $23.25 | 2019 | |
| Blue Earth Diagnostics | $18.64 | 2019 | |
| Coloplast Corp | $16.74 | 2019 | |
| Pfizer INC. | $16.39 | 2020 | |
| Smith+Nephew, INC. | $14.40 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw P Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.